en

PRODUCT DETAIL

Nucala 40 mg injekčný roztok v naplnenej injekčnej striekačke

Code 0819E
MA number EU/1/15/1043/010
Product Form: sol inj 3(3x1)x0,4 ml/40 mg (striek.inj.napl.skl.-multibal.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 14 - BRONCHODILATANTIA, ANTIASTHMATICA
ATC:
R RESPIRATORY SYSTEM
R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03D OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03DX Other systemic drugs for obstructive airway diseases
R03DX09 Mepolizumab
Shelf life: 36
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 02.12.2015
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 15.05.2022
eu-flag.png sk-flag.png